BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion
- PMID: 9365838
BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion
Abstract
A BCR/ABL-negative chronic myeloid leukemia (CML) with t(12;14) (p12;q11-13) as the sole chromosomal abnormality was investigated by fluorescence in situ hybridization (FISH), which disclosed a cryptic insertion of ETV6 (previously called TEL), located at 12p12, into ABL at chromosome band 9q34. ETV6/ABL fusion was confirmed by RT-PCR, revealing that the first five exons of ETV6 were fused in frame with ABL at exon 2. Wild-type ETV6 was expressed, in accordance with the FISH results showing no deletion of the second ETV6 allele. ETV6/ABL chimeric transcripts have previously been reported in acute leukemias, but never before in CML. The present case suggests that ETV6/ABL positivity may constitute a new genetic subgroup of BCR-negative CML.
Similar articles
-
Molecular and cytogenetic characterization of a novel rearrangement involving chromosomes 9, 12, and 17 resulting in ETV6 (TEL) and ABL fusion.Cancer Genet Cytogenet. 2005 Feb;157(1):74-7. doi: 10.1016/j.cancergencyto.2004.06.001. Cancer Genet Cytogenet. 2005. PMID: 15676152
-
Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia.Genes Chromosomes Cancer. 2001 Mar;30(3):274-82. Genes Chromosomes Cancer. 2001. PMID: 11170285
-
A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene.Genes Chromosomes Cancer. 2003 May;37(1):79-83. doi: 10.1002/gcc.10175. Genes Chromosomes Cancer. 2003. PMID: 12661008
-
[Genetic diagnosis of chronic myeloid leukemia].Nihon Rinsho. 2001 Dec;59(12):2336-41. Nihon Rinsho. 2001. PMID: 11766335 Review. Japanese.
-
The second ETV6 allele is not necessarily deleted in acute leukemias with a ETV6/ABL fusion.Genes Chromosomes Cancer. 1998 Mar;21(3):256-9. doi: 10.1002/(sici)1098-2264(199803)21:3<256::aid-gcc11>3.0.co;2-n. Genes Chromosomes Cancer. 1998. PMID: 9523202 Review.
Cited by
-
[The 8p11 myeloproliferative syndrome].Med Klin (Munich). 1999 Apr 15;94(4):207-10. doi: 10.1007/BF03044856. Med Klin (Munich). 1999. PMID: 10373756 Review. German.
-
Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders.Leukemia. 2008 Jul;22(7):1320-34. doi: 10.1038/leu.2008.133. Epub 2008 Jun 5. Leukemia. 2008. PMID: 18528425 Free PMC article.
-
A direct binding site for Grb2 contributes to transformation and leukemogenesis by the Tel-Abl (ETV6-Abl) tyrosine kinase.Mol Cell Biol. 2004 Jun;24(11):4685-95. doi: 10.1128/MCB.24.11.4685-4695.2004. Mol Cell Biol. 2004. PMID: 15143164 Free PMC article.
-
Characterization of leukemias with ETV6-ABL1 fusion.Haematologica. 2016 Sep;101(9):1082-93. doi: 10.3324/haematol.2016.144345. Epub 2016 May 26. Haematologica. 2016. PMID: 27229714 Free PMC article.
-
An ETV6-ABL1 fusion in a patient with chronic myeloproliferative neoplasm: Initial response to Imatinib followed by rapid transformation into ALL.Leuk Res Rep. 2016 Oct 14;6:50-54. doi: 10.1016/j.lrr.2016.09.002. eCollection 2016. Leuk Res Rep. 2016. PMID: 27812500 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous